328 related articles for article (PubMed ID: 11869017)
1. Prognostic value of proliferating cell nuclear antigen in Wilms' tumour in children.
Skotnicka-Klonowicz G; Kobos J; Łoś E; Trejster E; Szymik-Kantorowicz S; Daszkiewicz P
Eur J Surg Oncol; 2002 Feb; 28(1):67-71. PubMed ID: 11869017
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of p53 expression in Wilms' tumor in children.
Skotnicka-Klonowicz G; Kobos J; Łoś E; Trejster E; Szymik-Kontorowicz S; Daszkiewicz P
Med Sci Monit; 2001; 7(6):1224-9. PubMed ID: 11687734
[TBL] [Abstract][Full Text] [Related]
3. The prognostic relevance of preoperative transcatheter arterial chemoembolization (TACE) and PCNA/VEGF expression in patients with Wilms' tumour.
Liu WG; Gu WZ; Zhou YB; Tang HF; Li MJ; Ma WX
Eur J Clin Invest; 2008 Dec; 38(12):931-8. PubMed ID: 19021718
[TBL] [Abstract][Full Text] [Related]
4. 16q heterozygosity loss in Wilms' tumour in children and its clinical importance.
Skotnicka-Klonowicz G; Rieske P; Bartkowiak J; Szymik-Kantorowicz S; Daszkiewicz P; Debiec-Rychter M
Eur J Surg Oncol; 2000 Feb; 26(1):61-6. PubMed ID: 10718182
[TBL] [Abstract][Full Text] [Related]
5. Expression of proliferating cell nuclear antigen in Wilms' tumor.
Chen F; Liu G; Zhang Z; Li Z; Cai W
Chin Med J (Engl); 1997 May; 110(5):352-3. PubMed ID: 9594301
[TBL] [Abstract][Full Text] [Related]
6. Analysis of relative proliferation rates of Wilms' tumor components using proliferating cell nuclear antigen and MIB-1 (Ki-67 equivalent antigen) immunostaining and assessment of mitotic index.
Khine MM; Aung W; Sibbons PD; Howard CV; Clapham E; McGill F; Van Velzen D
Lab Invest; 1994 Jan; 70(1):125-9. PubMed ID: 7905542
[TBL] [Abstract][Full Text] [Related]
7. Assessment of proliferative activity in Wilms' tumour.
Delahunt B; Farrant GJ; Bethwaite PB; Nacey JN; Lewis ME
Anal Cell Pathol; 1994 Aug; 7(2):127-38. PubMed ID: 7993823
[TBL] [Abstract][Full Text] [Related]
8. Tumour cell proliferation rate as determined by MIB-1 antibody in Wilms' tumour.
Juszkiewicz P; Tuziak T; Zbisławski W; Liebhard M; Chosia M
Pol J Pathol; 1997; 48(2):113-9. PubMed ID: 9278108
[TBL] [Abstract][Full Text] [Related]
9. [Immunohistochemical evaluation of the percentage of proliferating neoplastic cells of Wilms' tumor in children by means of the MIB-1 monoclonal antibody].
Juszkiewicz P
Ann Acad Med Stetin; 1997; 43():113-27. PubMed ID: 9471911
[TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity of WT1 gene in the prognosis of sporadic Wilms' tumour in children.
Skotnicka-Klonowicz G; Rieske P; Bartkowiak J; Szymik-Kantorowicz S; Daszkiewicz P; Debiec-Rychter M
Anticancer Res; 1999; 19(2B):1451-4. PubMed ID: 10365122
[TBL] [Abstract][Full Text] [Related]
11. C-kit protein expression in Wilms' tumour: an immunohistochemical study.
Giordano G; Campanini N; Rocco A; Donofrio V; Bertolini P; Falleti J; Pettinato G
Eur J Surg Oncol; 2009 Jun; 35(6):629-35. PubMed ID: 19010635
[TBL] [Abstract][Full Text] [Related]
12. Minichromosome maintenance 2 (MCM2) is a new prognostic proliferative marker in Wilms tumour.
Taran K; Sitkiewicz A; Andrzejewska E; Kobos J
Pol J Pathol; 2011; 62(2):84-8. PubMed ID: 21866463
[TBL] [Abstract][Full Text] [Related]
13. Proliferating cell nuclear antigen (PCNA) expression as a prognostic indicator for renal cell carcinoma: comparison with tumour grade, mitotic index, and silver-staining nucleolar organizer region numbers.
Delahunt B; Bethwaite PB; Nacey JN; Ribas JL
J Pathol; 1993 Aug; 170(4):471-7. PubMed ID: 8105046
[TBL] [Abstract][Full Text] [Related]
14. Progression of localised Wilms' tumour during preoperative chemotherapy is an independent prognostic factor: a report from the SIOP 93-01 nephroblastoma trial and study.
Ora I; van Tinteren H; Bergeron C; de Kraker J;
Eur J Cancer; 2007 Jan; 43(1):131-6. PubMed ID: 17084075
[TBL] [Abstract][Full Text] [Related]
15. The significance of VEGF-C/VEGFR-2 interaction in the neovascularization and prognosis of nephroblastoma (Wilms' tumour).
Nowicki M; Ostalska-Nowicka D; Kaczmarek M; Miskowiak B; Witt M
Histopathology; 2007 Feb; 50(3):358-64. PubMed ID: 17257131
[TBL] [Abstract][Full Text] [Related]
16. [Significance of PCNA proliferating fraction for prognosis of ovarian carcinoma].
Schönborn I; Minguillon C; Reles A; Bartel U; Lichtenegger W
Geburtshilfe Frauenheilkd; 1996 Jul; 56(7):357-64. PubMed ID: 8964450
[TBL] [Abstract][Full Text] [Related]
17. Expression and prognostic significance of proliferating cell nuclear antigen and Ki-67 in malignant ovarian germ cell tumors.
Liu FS; Chen JT; Liu SC; Shih A; Shih RT; Ho ES
Zhonghua Yi Xue Za Zhi (Taipei); 1999 Oct; 62(10):695-702. PubMed ID: 10533299
[TBL] [Abstract][Full Text] [Related]
18. Expression of glucose transporter-1, hexokinase-II, proliferating cell nuclear antigen and survival of patients with pancreatic cancer.
Lyshchik A; Higashi T; Hara T; Nakamoto Y; Fujimoto K; Doi R; Imamura M; Saga T; Togashi K
Cancer Invest; 2007; 25(3):154-62. PubMed ID: 17530485
[TBL] [Abstract][Full Text] [Related]
19. [Anaplastic type of Wilms' tumour].
Vujanić GM; Aleksandrović S
Srp Arh Celok Lek; 1990; 118(9-10):353-6. PubMed ID: 1966350
[TBL] [Abstract][Full Text] [Related]
20. Clinical and prognostic significance of Ki-67 and proliferating cell nuclear antigen expression in childhood primitive neuroectodermal brain tumors.
Bodey B; Bodey B; Gröger AM; Siegel SE; Kaiser HE
Anticancer Res; 1997; 17(1A):189-96. PubMed ID: 9066650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
